Photo credits to the owner |
May 2014, it was recommended by the FDA advisory panel the
approval of the new CPR device. February 2015, the US FDA (Food and Drug
Administration) approved the premarket of the ResQCPR system of Zoll Medicalm
Chelmsford, MA. This system is designed to assist in cardiopulmonary
resuscitation performance. According to the company, they expect the new system
Basically, the ResQCPR system is composed of two devices.
Photo credits to owner |
First, the ResQPump. It has a double-grip handles with a
suction cup that will be attached to the patient's chest. This part of the
system is responsible in helping the rescuer maintain the correct compression
rate and compression depth. In short, this is the active
compression/decompression device.
Second, the ResQPod. It has an impedance-threshold valve
which is place in the patient's mouth so to limit the passive lung inflation
every time the chest-decompression is done. The valve will boost the
intrathoracic pressures and will then enhance the heart and brain perfusion.
Overall, this new CPR system is created to aid regulate
negative intrathoracic pressure to enhance blood flow during the states of poor
perfusion like in shock and cardiac arrest.
No comments:
Post a Comment